Types of Congenital Heart Defects

mediterranean genetic disorders :: Article Creator The 10 Biggest Science Stories Of 2023 – Chosen By Scientists 1. India's lunar lander reaches the dark side of the moon While western billionaires were busy sending rockets to space only for them to crash and burn, scientists in India were quietly doing something no one had accomplished before. Their Chandrayaan-3 moon lander was the first mission to reach the lunar south pole – an unexplored region where reservoirs of frozen water are believed to exist. I remember my heart soaring when images of the control room in India spread around social media, showing senior female scientists celebrating their incredible achievement. The success of Chandrayaan-3, launched in July 2023, showed the world that not only is India a major player in space, but that a moon lander can be launched successfully for $75m (£60m). This cost is not to be sniffed at but it is much cheaper than most other countries...

coronary artery disease young age :: Article Creator Coronary Heart Disease Before Age 45 May Increase Risk Of Dementia Later In Life Adults diagnosed with coronary heart disease, especially before the age of 45, may be at increased risk of developing dementia, Alzheimer's disease and vascular dementia later in life, according to new research published today in the Journal of the American Heart Association. "Coronary heart disease has previously been associated with dementia risk in older adults; however, this is believed to be the first large-scale study examining whether the age of coronary heart disease onset may impact the risk of developing dementia later in life," said Fanfan Zheng, Ph.D., senior study author and researcher in the School of Nursing at the Chinese Academy of Medical Sciences & Peking Union Medical College in Beijing, China. "In previous research, we found that adults experienced accelerated cognit...

severe multivessel coronary artery disease :: Article Creator Coronary Artery Disease Coronary artery disease (CAD; also atherosclerotic heart disease) is the end result of the accumulation of atheromatous plaques within the walls of the coronary arteries that supply the myocardium (the muscle of the heart) with oxygen and nutrients. It is sometimes also called coronary heart disease (CHD). Although CAD is the most common cause of CHD, it is not the only one. CAD is the leading cause of death worldwide. While the symptoms and signs of coronary artery disease are noted in the advanced state of disease, most individuals with coronary artery disease show no evidence of disease for decades as the disease progresses before the first onset of symptoms, often a "sudden" heart attack, finally arises. After decades of progression, some of these atheromatous plaques may rupture and (along with the activation of the blood clotting system) start lim...

achondroplasia genetics :: Article Creator Vosoritide Beneficial For Children Younger Than 5 Years With Achondroplasia WEDNESDAY, Dec. 27, 2023 (HealthDay News) — For children with achondroplasia, vosoritide is associated with a gain in the change in height Z score from baseline and a mild adverse event profile, according to a study published in the January issue of The Lancet Child & Adolescent Health. Ravi Savarirayan, M.D., from the Royal Children's Hospital at the University of Melbourne in Australia, and colleagues conducted a double-blind, randomized phase 2 trial in 16 hospitals across Australia, Japan, the United Kingdom, and the United States to examine the safety and efficacy of vosoritide in children younger than 60 months with a clinical diagnosis of achondroplasia confirmed by genetic testing. Participants were enrolled into three cohorts based on age at screening: 24 to 59 months, 6 to 23 months, and 0 to 5 months (cohorts 1,...

cardiac syndrome x :: Article Creator Top Heart Disease Treatment And Prevention Advancements In 2023 Heart disease affects millions of people every year. Several advancements in treatment and prevention occurred throughout 2023. Among these innovations are new injectable medications that are making treatment easier and more effective. As 2023 comes to a close, cardiologists are reflecting on some of the advancements and breakthroughs in their field over the past 12 months. Heart disease is a pressing issue in the United States. The American Heart Association reports that more than 130 million adults (about 45.1% of the population) will develop some form of cardiovascular disease by 2035, which will lead to $1.1 trillion in projected total costs. This reality means researchers and clinicians are invested nationwide in developing better interventions and treatments to address the rising prevalence of heart disease among Americans. To ...